INVO Fertility (IVF) EPS (Basic) Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -16.42% |
| Jun 30, 2025 | -118.02% |
| Mar 31, 2025 | -112.38% |
| Dec 31, 2024 | 182.93% |
| Sep 30, 2024 | -151.56% |
| Jun 30, 2024 | -275.48% |
| Mar 31, 2024 | -379.59% |
| Dec 31, 2023 | -551.83% |
| Sep 30, 2023 | -222.72% |
| Jun 30, 2023 | -214.16% |
| Mar 31, 2023 | -426.89% |
| Dec 31, 2022 | -402.10% |
| Sep 30, 2022 | -424.77% |
| Jun 30, 2022 | -444.02% |
| Mar 31, 2022 | -172.64% |
| Dec 31, 2021 | 37.97% |
| Sep 30, 2021 | -175.22% |
| Jun 30, 2021 | -76.23% |
| Mar 31, 2021 | -185.30% |
| Dec 31, 2020 | -216.18% |
| Sep 30, 2020 | -226.13% |
| Jun 30, 2020 | -46.51% |
| Mar 31, 2020 | -199.29% |
| Dec 31, 2019 | -51.57% |
| Sep 30, 2019 | -169.42% |
| Jun 30, 2019 | -78.05% |
| Mar 31, 2019 | -23.09% |
| Dec 31, 2018 | -32.14% |
| Sep 30, 2018 | -0.48% |
| Jun 30, 2018 | -58.23% |
| Mar 31, 2018 | 19.08% |
| Dec 31, 2017 | -24.14% |
| Sep 30, 2017 | 17.32% |
| Jun 30, 2017 | 9.62% |
| Mar 31, 2017 | 11.76% |
| Dec 31, 2016 | -37.97% |
| Sep 30, 2016 | -8.73% |
| Jun 30, 2016 | -20.11% |